{
    "code": "02024275",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024275",
    "time": "2019-05-17 03:37:11",
    "許可證字號": "衛署藥輸字第024275號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "109\/07\/27",
    "發證日期": "94\/07\/27",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202427502",
    "中文品名": "利憶靈持續性藥效膠囊8毫克",
    "英文品名": "REMINYL PROLONGED RELEASE CAPSULES 8MG",
    "適應症": "治療ALZHEIMER症輕度至中度嚴重癡呆",
    "劑型": "133持續性藥效膠囊劑",
    "包裝": "2-1000粒鋁箔盒裝 2-1000粒塑膠瓶裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "GALANTAMINEHYDROBROMIDE"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "1507401100  嬌生股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "FIT0332000  JANSSEN-CILAG S.P.A.",
        "製造廠廠址": "VIA C. JANSSEN 04100 BORGO S. MICHELE-LATINA, ITALY",
        "製造廠公司地址": "VIA M. BUONARROTI 23 20093 COLOGNO MONZESE ITALY"
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "6605071926  久裕企業股份有限公司(委託包裝)",
            "製造廠廠址": "桃園市桃園區大林里興邦路43巷2之1號4樓，3樓B區，1樓A區",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "貼標廠"
        },
        {
            "製造廠名稱": "FBE0079000  JANSSEN PHARMACEUTICA N.V.",
            "製造廠廠址": "LAMMERDRIES 55 2250 OLEN, BELGIUM",
            "製造廠公司地址": "",
            "製造廠國別": "BELGIUM",
            "製程": "半成品(BULK MICROSPHERE)"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200042310",
            "成分名稱": "GALANTAMINE HYDROBROMIDE",
            "含量描述": "",
            "含量": "10.2500000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "[打樣版] Reminyl PR Cap_CCDS 20Aug2016_v1801_0111-108-03-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024275&Seq=022&Type=9"
        },
        {
            "title": "PI_Reminyl PR Cap_CCDS 02Aug2016_v1701-106-03-27.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024275&Seq=020&Type=9"
        },
        {
            "title": "Reminyl 8mg PR CSP 外觀-108-03-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024275&Seq=013&Type=8"
        },
        {
            "title": "Reminyl PR Cap 8mg-foil-105-12-13.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024275&Seq=011&Type=8"
        }
    ]
}